The Beat with Joel Dunning Ep. 34: An Interview with Michael Mack [1]
In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years [3]
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here. [4]